Invention Grant
- Patent Title: T cell expansion
-
Application No.: US15290230Application Date: 2016-10-11
-
Publication No.: US10052372B2Publication Date: 2018-08-21
- Inventor: Peter Wang , Chunxiao Wu
- Applicant: Tessa Therapeutics Pte Ltd
- Applicant Address: SG Singapore
- Assignee: TESSA THERAPEUTICS PTE LTD
- Current Assignee: TESSA THERAPEUTICS PTE LTD
- Current Assignee Address: SG Singapore
- Agency: Swanson & Bratschun, L.L.C.
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K35/17 ; A61K39/00 ; C12N5/0783

Abstract:
A method of treating a cancer in a subject is disclosed, comprising: (1) isolating T cells from a subject; generating or expanding a population of T cells specific for a virus by a method comprising: stimulating T cells by culture in the presence of antigen presenting cells (APCs) presenting a peptide of the virus, wherein 10 to 25% of the media in which the cells are cultured is conditioned media obtained from a stimulation culture comprising T cells and APCs presenting a peptide of the virus; and (3) administering the generated or expanded population of T cells to a subject. Also disclosed are methods for generating or expanding a population of T cells specific for a virus.
Public/Granted literature
- US20170028042A1 T Cell Expansion Public/Granted day:2017-02-02
Information query